CO-HEP Symposium - 20-year Anniversary of Copenhagen Hepatitis C Program (CO-HEP)

We have the pleasure of inviting you to celebrate the 20-year Anniversary of Copenhagen Hepatitis C Program (CO-HEP) following the HCV-Flavi2026 Congress.


We look forward to a great day of science with invited speakers, friends and collaborators within virology and immunology research.

Register here for free: https://cappartner.eventsair.com/hcv-flavi-2026/registrationforcoheponly/Site/Register

Best wishes,
Jens Bukh, Judith M. Gottwein and Troels K. H. Scheel

Programme

09:30       Welcome
Charlotte Menne Bonefeld, University of Copenhagen (DK)  – ISIM and the CO-HEP Center

Thomas Benfield, Hvidovre Hospital (DK) – Infectious Diseases and CO-HEP

Jens Bukh, Judith M. Gottwein and Troels K. H. Scheel – CO-HEP - a new virus initiative in Copenhagen

09:50        
T. Jake Liang, National Institutes of Health (US) – From Denmark to America and back: the journey of Vikings in the science of hepatitis C

10:10        
Jean-Michel Pawlotsky, Hôpital Henri Mondor, Université Paris-Est, Créteil (FR) – HCV elimination in the DAA era: tackling the remaining challenges

10:30        
Nina Weis, Hvidovre Hospital (DK) – 20 years of clinical and translational hepatitis research in Denmark

10:50        
John Law, Memorial University of Newfoundland (CA) – Genotype specific humoral response against HCV

11:10        
Rowena Bull, University of New South Wales (AU) – B-cell immunology in acute viral diseases

11:30        
Mansun Law, The Scripps Research Institute (US) – HCV Broadly Neutralizing Antibodies

11:50        Lunch            

12:35        
CO-HEP Investigators - Highlights of what shaped virus research in CO-HEP

12:55
Clara T. Schoeder, Liepzig University (DE) – Antigen design with computational protein design tools for (re-)emerging viruses

13:15       
Philip Meuleman, Ghent University (BE) – Mice with humanized liver for the study of viral hepatitis

13:35        
Joy Tomlinson, University of Pennsylvania (US) – Viral determinants of transmissible liver disease in equids

13:55        
Amit Kapoor, Nationwide Children’s Hospital (US) – Latest on infection and immunity of rat Hepacivirus and Pegivirus in mouse models

14:15        Coffee           

14:35        
Thomas Pietschmann, Twincore Hannover (DE) – Diversity and plasticity: the curse and key to HCV vaccine development

14:55        
Volker Lohmann, Heidelberg University (DE) – Evolution of highly replicating HCV variants and their contribution to pathogenesis"

15:15        
Joseph Luna, Case Western Reserve University (US) – Teaching RNA binding proteins to do new things

15:35        
Pablo Gastaminza, National Center for Biotechnology (ES) – Insight into the mode of action of a family of antivirals with pan-coronavirus potential

15:55        
Peter Simmonds, University of Turku (FI) – From HCV genotypes to the deeper origins of RNA viruses – adventures in virus taxonomy

16:15        Reception